Back
Speaker illustration

Doctor Hanna Gaggin

Massachusetts General Hospital, Boston (United States of America)

Presentations

Panel discussion and Q&A

Event: Heart Failure 2025

Topic: Cardiac Amyloidosis

Session: ATTR cardiomyopathy: from current practices to future treatment and monitoring

Access
Like
Thumbnail

Exploring future horizons in ATTR cardiomyopathy

Event: Heart Failure 2025

Topic: Cardiac Amyloidosis

Session: ATTR cardiomyopathy: from current practices to future treatment and monitoring

Access
Like
Thumbnail

Management of patients with ATTR cardiomyopathy

Event: Heart Failure 2025

Topic: Cardiac Amyloidosis

Session: ATTR cardiomyopathy: from current practices to future treatment and monitoring

Access
Like
Thumbnail

Unravelling ATTR cardiomyopathy

Event: Heart Failure 2025

Topic: Cardiac Amyloidosis

Session: ATTR cardiomyopathy: from current practices to future treatment and monitoring

Access
Like
Thumbnail

Faculty discussion - How heart failure biomarkers change clinical practice in the management of acute heart failure.

Event: Heart Failure 2019

Topic: Acute Heart Failure

Session: How heart failure biomarkers change clinical practice in the management of acute heart failure

Access
Like
Thumbnail

Role of NT-proBNP in acute heart failure diagnosis and treatment.

Event: Heart Failure 2019

Topic: Biomarkers

Session: How heart failure biomarkers change clinical practice in the management of acute heart failure

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources